UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 160

Sortiert nach

Generalizability of SPRINT Results to the U.S. Adult Population

Journal of the American College of Cardiology, 2016-02, Vol.67 (5), p.463-472

2016

Volltextzugriff (PDF)

Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction

JACC. Heart failure, 2016-05, Vol.4 (5), p.392-402

2016

Volltextzugriff (PDF)

Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study

PloS one, 2022-08, Vol.17 (8), p.e0270675

2022

Volltextzugriff (PDF)

Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020

Journal of the American Heart Association, 2023-06, Vol.12 (11), p.e028573-e028573

2023

Volltextzugriff (PDF)

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT

Journal of the American Heart Association, 2018-09, Vol.7 (18), p.e009326

2018

Volltextzugriff (PDF)

Potential impact of systematic and random errors in blood pressure measurement on the prevalence of high office blood pressure in the United States

The journal of clinical hypertension (Greenwich, Conn.), 2022-03, Vol.24 (3), p.263-270

2022

Volltextzugriff (PDF)

Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study

PloS one, 2022-04, Vol.17 (4), p.e0266481

2022

Volltextzugriff (PDF)

Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2470-2480

2017

Volltextzugriff (PDF)

Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic

Journal of the American Heart Association, 2021-06, Vol.10 (11), p.e020997

2021

Volltextzugriff (PDF)

Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study

Journal of the American Heart Association, 2024-01, Vol.13 (2), p.e032370-e032370

2024

Volltextzugriff (PDF)

Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States

Journal of the American Heart Association, 2024-01, Vol.13 (1), p.e032413-e032413

2024

Volltextzugriff (PDF)

Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States

Journal of the American Heart Association, 2024-03, Vol.13 (5), p.e031717

2024

Volltextzugriff (PDF)

Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

Journal of the American Heart Association, 2024-02, Vol.13 (3), p.e031574-e031574

2024

Volltextzugriff (PDF)

Trends in Hypertension Clinical Trials Focused on Interventions Specific for Black Adults: An Analysis of ClinicalTrials.gov

Journal of the American Heart Association, 2020-12, Vol.9 (24), p.e018512-e018512

2020

Volltextzugriff (PDF)

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial

American journal of hypertension, 2018-01, Vol.31 (1), p.97-107

2018

Volltextzugriff (PDF)

Genetics of Blood Pressure: New Insights Into a Complex Trait

American journal of kidney diseases, 2017-06, Vol.69 (6), p.723-725

2017

Volltextzugriff (PDF)

New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT

Journal of the American Heart Association, 2023-09, Vol.12 (17), p.e030311-e030311

2023

Volltextzugriff (PDF)

Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation

The Annals of pharmacotherapy, 2013-05, Vol.47 (5), p.628

2013

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015–2020

American journal of preventive cardiology, 2024-03, Vol.17, p.100624-100624, Article 100624

2024

Volltextzugriff (PDF)

Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life

JAMA : the journal of the American Medical Association, 2018-11, Vol.320 (17), p.1774

2018

Volltextzugriff (PDF)

Entering a New Era of Antihypertensive Therapy

American journal of kidney diseases, 2024-03, Vol.83 (3), p.411-414

2024

Volltextzugriff (PDF)

Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans

Journal of the American Heart Association, 2021-04, Vol.10 (8), p.e019254-e019254

2021

Volltextzugriff (PDF)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina

Journal of the American Heart Association, 2019-08, Vol.8 (15), p.e012811-e012811

2019

Volltextzugriff (PDF)

Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart Study

Journal of the American Heart Association, 2019-08, Vol.8 (16), p.e011897-e011897

2019

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(149)

Publikationsform

Artikel
(159)
Tagungsberichte
(1)

Sprache

Englisch
(160)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(109)
Humans
(97)
Cardiovascular System & Cardiology
(75)
Hypertension
(62)
Female
(59)
Male
(57)
Blood Pressure
(55)
Aged
(52)
Middle Aged
(43)
Cardiac & Cardiovascular Systems
(42)
Hypertension - Drug Therapy
(42)
Antihypertensive Agents - Therapeutic Use
(39)
Peripheral Vascular Disease
(39)
Adult
(34)
Hypertension - Epidemiology
(27)
Risk Factors
(26)
United States - Epidemiology
(26)
Cardiovascular Disease
(24)
Blood Pressure - Physiology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Generalizability of SPRINT Results to the U.S. Adult Population

Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction

Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study

Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans

Potential impact of systematic and random errors in blood pressure measurement on the prevalence of high office blood pressure in the United States

Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study

Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study

Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic

Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study

Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States

Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States

Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

Trends in Hypertension Clinical Trials Focused on Interventions Specific for Black Adults: An Analysis of ClinicalTrials.gov

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial

Genetics of Blood Pressure: New Insights Into a Complex Trait

New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT

Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation

Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015–2020

Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life

Entering a New Era of Antihypertensive Therapy

Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina

Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart Study

Suchergebnisse filtern